Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soheil Meshinchi

Showing results (91-100 of 218) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|February 25, 2014
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupGeorge S Laszlo, Rhonda E Ries, Chelsea J Gudgeon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Cancer|April 29, 2014
AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemiaTodd M Cooper, Todd A Alonzo, Robert B Gerbing, et al.
Hematological Oncology|January 18, 2025
Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative NeoplasmsTariq I Mughal, John Mascarenhas, Raajit K Rampal, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid LeukemiaLauren M Harmon, Zachary S Hattig, Yizhou Peter Huang, et al.
Journal of Proteome Research|August 21, 2012
Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data setsEric J Foss, Dragan Radulovic, Derek L Stirewalt, et al.
Pediatric Blood & Cancer|September 2, 2021
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology GroupKelly D Getz, Todd A Alonzo, Lillian Sung, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Blood|March 24, 2009
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Cancer Genetics|July 12, 2015
Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology GroupMarijana Vujkovic, Edward F Attiyeh, Rhonda E Ries, et al.
Pageof 22

Showing results (91-100 of 218) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|February 25, 2014
High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupGeorge S Laszlo, Rhonda E Ries, Chelsea J Gudgeon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Cancer|April 29, 2014
AAML0523: a report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemiaTodd M Cooper, Todd A Alonzo, Robert B Gerbing, et al.
Hematological Oncology|January 18, 2025
Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative NeoplasmsTariq I Mughal, John Mascarenhas, Raajit K Rampal, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Germline Variant Burden Warrants Universal Genetic Testing in Pediatric Myeloid LeukemiaLauren M Harmon, Zachary S Hattig, Yizhou Peter Huang, et al.
Journal of Proteome Research|August 21, 2012
Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data setsEric J Foss, Dragan Radulovic, Derek L Stirewalt, et al.
Pediatric Blood & Cancer|September 2, 2021
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology GroupKelly D Getz, Todd A Alonzo, Lillian Sung, et al.
Transplantation and Cellular Therapy|June 18, 2022
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular TherapyKatherine Tarlock, Maria Luisa Sulis, Joseph H Chewning, et al.
Blood|March 24, 2009
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupPhoenix A Ho, Todd A Alonzo, Robert B Gerbing, et al.
Cancer Genetics|July 12, 2015
Concordance of copy number alterations using a common analytic pipeline for genome-wide analysis of Illumina and Affymetrix genotyping data: a report from the Children's Oncology GroupMarijana Vujkovic, Edward F Attiyeh, Rhonda E Ries, et al.
Pageof 22